Hunan Er Kang Pharmaceutical Asset Resilience Ratio

Latest as of June 2025: 1.19%

Hunan Er Kang Pharmaceutical asset resilience ratio. Hunan Er Kang Pharmaceutical (300267) has an Asset Resilience Ratio of 1.19% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hunan Er Kang Pharmaceutical defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥60.00 Million

≈ $8.78 Million USD Cash + Short-term Investments

Total Assets

CN¥5.05 Billion

≈ $738.96 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Hunan Er Kang Pharmaceutical (2015–2024)

Asset resilience ratio of Hunan Er Kang Pharmaceutical from 2015 to 2024. This chart shows how Hunan Er Kang Pharmaceutical's Asset Resilience Ratio has changed over time. Read total liabilities of Hunan Er Kang Pharmaceutical for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hunan Er Kang Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Hunan Er Kang Pharmaceutical.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥60.00 Million	1.19%
Total Liquid Assets	CN¥60.00 Million	1.19%

Asset Resilience Insights

Limited Liquidity: Hunan Er Kang Pharmaceutical maintains only 1.19% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hunan Er Kang Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Hunan Er Kang Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Hunan Er Kang Pharmaceutical Asset Resilience Ratio by Year (2015–2024)

Hunan Er Kang Pharmaceutical asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Hunan Er Kang Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.31%	CN¥120.00 Million ≈ $17.56 Million	CN¥5.20 Billion ≈ $760.88 Million	+2.31pp
2023-12-31	0.00%	CN¥118.60K ≈ $17.35K	CN¥5.48 Billion ≈ $801.76 Million	-1.95pp
2022-12-31	1.95%	CN¥114.12 Million ≈ $16.70 Million	CN¥5.86 Billion ≈ $856.87 Million	+1.87pp
2020-12-31	0.08%	CN¥5.30 Million ≈ $775.97K	CN¥6.55 Billion ≈ $958.00 Million	-2.00pp
2015-12-31	2.08%	CN¥100.00 Million ≈ $14.63 Million	CN¥4.80 Billion ≈ $702.59 Million	--

pp = percentage points

About Hunan Er Kang Pharmaceutical

SHE:300267 China Drug Manufacturers - Specialty & Generic

Market Cap

$890.38 Million

CN¥6.08 Billion CNY

Market Cap Rank

#9116 Global

#2200 in China

Share Price

CN¥2.95

Change (1 day)

+1.37%

52-Week Range

CN¥2.77 - CN¥4.84

All Time High

CN¥17.60